Mucormycosis is a rare fungal infection, with high morbidity and mortality. Palatal ulceration may suggest a number of differential diagnoses, one of which is rhinocerebral/craniofacial mucormycosis and for which it may be the first presenting clinical finding. We report a case of sinus mucormycosis in a patient with chronic myelomonocytic leukaemia‐2 (CMML‐2), now classified in the myelodysplastic/myeloproliferative neoplasms, presenting with dental pain and palatal ulcer.
Case presentation:
A 72‐year‐old female with CMML‐2 presented with pain of the left maxillary molar and a dark‐brown necrotic ulcer with a white irregular border on the hard palate. Invasive fungal infection was included in the differential diagnosis. Computerized tomography disclosed inflammatory lesions in the left nasal, ethmoid and frontal sinuses. Histological examination of the ulcer showed fungal hyphae typical of agents of mucormycosis. Rhizopus arrhizus was isolated from the culture. Liposomal amphotericin B was introduced, combined with haematological support and maxillectomy. Mucormycosis was controlled, but the patient died of progressive acute myeloid leukaemia and multiple bacteraemias. A literature review of rhinocerebral mucormycosis with palatal involvement disclosed 109 cases; palatal involvement was present among other presenting signs in 34 patients and as the presenting sign leading to diagnosis in nine cases, including the present case. Six of the nine patients (66.6 %) survived the infection, compared with 43 of 101 (42.6 %) with other signs at presentation.
Conclusion:
Palatal ulcer may represent an early sign of sinus mucormycosis. Awareness by healthcare professionals is critical for the prompt diagnosis of this rapidly developing and life‐threatening infection.
BallesterD.G.,
Gonzalez‐GarciaR.,
GarciaC.M.,
Ruiz‐LazaL.,
GilF.M.(2012). Mucormycosis of the head and neck: report of five cases with different presentations. J Cranio‐Maxillo‐Facial Surg 40:584–591[CrossRef]
DoniB.R.,
PeerapurB.V.,
ThotappaL.H.,
HippargiS.B.(2011). Sequence of oral manifestations in rhino‐maxillary mucormycosis. Indian J Dent Res 22:331–335[CrossRef]
KarabulutA.B.,
KabakasF.,
BerkozO.,
KarakasZ.,
KesimS.N.(2005). Hard palate perforation due to invasive aspergillosis in a patient with acute lymphoblastic leukemia. Int J Pediatr Otorhinolaryngol 69:1395–1398[CrossRef]
KimJ.,
FortsonJ.F.,
CookH.E.(2001). A fatal outcome from rhinocerebral mucormycosis after dental extractions: a case report. J Oral Maxillofac Surg 59:693–697[CrossRef]
LanternierF.,
DannaouiE.,
MorizotG.,
ElieC.,
Garcia‐HermosoD.,
HuerreM.,
BitarD.,
DromerF.,
LortholaryO.the French Mycosis Study Group(2012). A global analysis of mucormycosis in France: the RetroZygo study (2005–2007). Clin Inf Dis 54: (Suppl.1) S35–S43[CrossRef]
LewisR.E.,
LiaoG.,
WangW.,
PrinceR.A.,
KontoyiannisD.P.(2011). Voriconazole pre‐exposure selects for breakthrough mucormycosis in a mixed model of Aspergillus fumigatus–Rhizopus oryzae pulmonary infection. Virulence 2:348–355[CrossRef]
LlataE.,
BlossomD.B.,
KhouryH.J.,
RaoC.Y.,
WannemuehlerA.,
Noble‐WangJ.,
LangstonA.,
RibnerB.S.,
LyonG.M.other authors(2011). A cluster of mucormycosis infections in hematology patients: challenges in investigation and control of invasive mold infections in high‐risk patient populations. Diagn Microbiol Inf Dis 71:72–80[CrossRef]
ManeR.S.,
WatveJ.K.,
MohiteA.A.,
PatilB.C.(2007). Rhinocerebral mucormycosis: a deadly disease on the rise. Indian J Otolaryngol Head Neck Surg 59:112–115[CrossRef]
MetzenD.,
BohmH.,
ZimmermannM.,
ReutherT.,
KublerA.C.,
Muller‐RichterU.D.A.(2012). Mucormycosis of the head and neck. J Cranio‐Maxillo‐Facial Surg 40:e321–e327[CrossRef]
PapadogeorgakisN.,
PararaE.,
PetsinisV.,
VourlakouC.(2010). A case of successfully treated rhinocerebral mucormycosis: Dental implications. Int J Dent 2010:273127[CrossRef]
PrasadK.,
LalitbaR.M.,
ReddyE.K.,
RanganatbK.,
SrinivasD.R.,
SingbJ.(2012). Role of early diagnosis and multimodal treatment in rhinocerebral mucormycosis: experience of 4 cases. J Oral Maxillofac Surg 70:354–362[CrossRef]
SamantaD.R.,
SenapatiS.N.,
SharmaP.K.,
ShruthiB.S.,
PatyP.B.,
SarangiG.(2009). Hard palate perforation in acute lymphoblastic leukemia due to mucormycosis – a case report. Indian J Hematol Blood Transf 25:36–39[CrossRef]
SkiadaA.,
LanternierF.,
GrollA.H.,
PaganoL.,
ZimmerliS.,
HerbrechtR.,
LortholaryO.,
PetrikkosG.(2013). Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on infections in leukemia. Haematologica 98:492–504[CrossRef]
SkiadaA.,
PaganoL.,
GrollA.,
ZimmerliS.,
DupontB.,
LagrouK.,
Lass‐FlorlC.,
BouzaE.,
KlimkoN.other authors(2011). Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect 17:1859–1867[CrossRef]
VardimanJ.W.,
HarrisN.L.,
BrunningR.D.(2002). The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 100:2292–2302[CrossRef]
VardimanJ.W.,
ThieleJ.,
ArberD.A.,
BrunningR.D.,
BorowitzM.J.,
PorwitA.,
HarrisN.L.,
Le BeauM.M.,
Hellström‐LindbergE.other authors(2009). The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114:937–951[CrossRef]